At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BLRX BioLine Rx
Post-Mkt 11-02 16:34:16 EST
1.96
-0.03
-1.51%
盘后1.96
+0.000.00%
16:10 EST
High1.96
Low1.94
Vol4.70K
Open1.94
D1 Closing1.99
Amplitude1.01%
Mkt Cap9.76M
Tradable Cap9.24M
Total Shares4.98M
T/O9.15K
T/O Rate0.10%
Tradable Shares4.72M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Analysts Offer Insights on Healthcare Companies: Zentalis Pharmaceuticals (ZNTL), Bioline RX Ltd Sponsored ADR (BLRX) and Evaxion Biotech (EVAX)
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.